Creo Medical Limited
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	£25.16M N/A	£27.16M 7.98%	£30.8M 13.36%	Avg: £53.56M Low: £52.95M High: £54.09M avg. 73.92%	Avg: £69.87M Low: £68.64M High: £70.98M avg. 30.44%	Avg: £95.19M Low: £93.52M High: £96.71M avg. 36.23%
Net Income % change YoY	£-24.59M N/A	£-26.93M -9.51%	£-21.7M 19.43%	Avg: £-2.78M Low: £-3.13M High: £-2.03M avg. 87.17%	Avg: £5.10M Low: £4.33M High: £4.52M avg. 283.30%	Avg: £6.00M Low: £5.86M High: £6.12M avg. 17.66%
EBITDA % change YoY	£-27.39M N/A	£-27.69M -1.08%	£-20.7M 25.25%	Avg: £-50.43M Low: £-50.93M High: £-49.86M avg. -143.65%	Avg: £-65.79M Low: £-66.83M High: £-64.63M avg. -30.44%	Avg: £-89.63M Low: £-91.06M High: £-88.05M avg. -36.23%
EPS % change YoY	-$0.14 N/A	-$0.14 0%	-$0.07 50.5%	Avg: -$0.01 Low: -$0.01 High: -$0.01 avg. 88.70%	Avg: $0.01 Low: $0.01 High: $0.01 avg. 280.97%	Avg: $0.02 Low: $0.02 High: $0.02 avg. 35.36%
Operating Expenses % change YoY	£38.98M N/A	£40.81M 4.70%	£40.1M -1.75%	Avg: £8.18B Low: £8.09B High: £8.26B avg. 20317.29%	Avg: £10.67B Low: £10.49B High: £10.84B avg. 30.44%	Avg: £14.55B Low: £14.29B High: £14.78B avg. 36.23%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 129.38% in 2025-2027.

We have gathered data from 3 analysts. Their low estimate is -3.13M, average is -2.78M and high is -2.03M.

Wall Street analysts forecast annual average revenue growth of 46.86% in 2025-2027.

We have gathered data from 3 analysts. Their low revenue estimate is £52.95M, average is £53.56M and high is £54.09M.

Wall Street analysts forecast annual average earnings growth of 135.01% in 2025-2027.

We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.01, average is -$0.01 and high is £-0.00.